COVID-19 vaccination in Norway

COVID-19 vaccination in Norway is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. 870,524 people had been vaccinated with the first dose and 296,458 fully vaccinated as of 17 April 2021; mostly elderly people, healthcare workers and younger people at risk.

COVID-19 vaccination in Norway
Date27 December 2020 (2020-12-27) – present
LocationNorway
CauseCOVID-19 pandemic in Norway

In May 2021, an expert review commissioned by the Norwegian Medicines Agency to investigate "the cause of the first 100 reported deaths of nursing home residents who had received the Pfizer-BioNTech vaccine" concluded that "a causal link between the Pfizer-BioNTech vaccine and death was considered “likely” in 10 of the 100 cases, “possible” in 26 cases, and “unlikely” in 59 cases. The remaining five were deemed “unclassifiable.”"[1]

Norway is also closely monitoring side effects, with both reports from healthcare professionals and the public being registered in a common database. This should allow for a good overview of the situation once the vaccine is distributed in the general population, as well as an efficient collaboration with other countries. [2][3]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

Vaccine Approval Deployment
Pfizer–BioNTech 21 December 2020 27 December 2020
Moderna 6 January 2021 12 January 2021
Oxford-AstraZeneca 29 January 2021 7 February 2021
Janssen 11 March 2021 5 May 2021
CureVac Pending Pending
Novavax Pending Pending
Valneva Pending Pending
Sanofi–GSK Pending Pending

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.